You are here

Omecamtiv Mecarbil

FDA turns down Cytokinetics’ once-promising heart failure drug omecamtiv

Fierce Pharma

Tue, 02/28/23 - 10:51 pm

complete response letter

Omecamtiv Mecarbil

FDA advisers nix Cytokinetics' heart failure med, rejecting argument for subgroup use

Fierce Biotech

Tue, 12/13/22 - 11:56 pm

Omecamtiv Mecarbil

Ahead of adcomm, FDA raises uncertainties on benefit-risk profile of Cytokinetics' potential heart drug

Endpoints

Sun, 12/11/22 - 01:28 pm

Omecamtiv Mecarbil

Cytokinetics aims to become the Vertex of cardiovascular disease

EP Vantage

Thu, 06/16/22 - 10:19 am

Omecamtiv Mecarbil

cardiovascular disease

Cytokinetics hopes to resurrect omecamtiv

EP Vantage

Wed, 01/19/22 - 11:08 am

Omecamtiv Mecarbil

Abandoned by Amgen, Cytokinetics lands $50M upfront deal for Chinese rights to heart failure prospect

Fierce Biotech

Tue, 12/21/21 - 10:34 am

Omecamtiv Mecarbil

Ji Xing Pharmaceuticals

ACC 2021: With Amgen out of the picture, Cytokinetics imagines supporting role for omecamtiv in heart failure

Fierce Biotech

Mon, 05/17/21 - 10:48 am

Omecamtiv Mecarbil

AHA 2020 – look out for the omecamtiv fault lines

EP Vantage

Mon, 11/16/20 - 10:13 am

Omecamtiv Mecarbil

Amgen and Cytokinetics claim heart drug success, but results widely disappoint

BioPharma Dive

Thu, 10/8/20 - 11:19 pm

clinical trials

Omecamtiv Mecarbil

cardiovascular disease

Trial of Amgen, Servier’s heart failure drug clears interim check

PM Live

Fri, 02/28/20 - 10:18 am

chronic heart failure

Omecamtiv Mecarbil

clinical trials

Amgen heart drug passes interim check, setting up year-end readout

BioPharma Dive

Wed, 02/26/20 - 11:24 pm

Omecamtiv Mecarbil

Amgen, Servier heart failure drug clears trial hurdle

PM Live

Thu, 03/21/19 - 06:50 pm

Omecamtiv Mecarbil

clinical trials

Amgen and partners begin second phase 3 trial of omecamtiv mecarbil in patients with heart failure

Pharmaceutical Business Review

Fri, 02/22/19 - 10:04 am

heart failure with reduced ejection fraction

Omecamtiv Mecarbil

Cytokinetics inches forward with heart failure program

BioPharma Dive

Thu, 08/3/17 - 10:57 am

Omecamtiv Mecarbil

The 3 Most Important Drugs in Amgen's Pipeline

Motley Fool

Fri, 12/4/15 - 08:17 pm

Omecamtiv Mecarbil

Amgen, Cytokinetics heart failure drug succeeds in mid-stage study

Yahoo/Reuters

Tue, 10/27/15 - 09:56 am

Omecamtiv Mecarbil

chronic heart failure

Cytokinetics Still Has Value, Despite Setbacks

Seeking Alpha

Thu, 05/8/14 - 08:28 am

Omecamtiv Mecarbil

Cytokinetics: 2014 Will Bring Critical Data Readouts On Tirasemtiv And Omecamtiv Mecarbil

Seeking Alpha

Sat, 11/2/13 - 11:19 am

Omecamtiv Mecarbil

Fallout From This Heart-Drug Failure

Motley Fool

Sat, 09/14/13 - 10:49 am

Omecamtiv Mecarbil

Cheers and Jeers for Amgen's Pipeline

Motley Fool

Thu, 09/12/13 - 08:13 am

Omecamtiv Mecarbil

Pages